Search Science Hub

Science Hub is Novo Nordisk’s one-stop portal for all our scientific publications and clinical trials, congress materials and medical updates. Sign up to gain full access.

Welcome to Novo Nordisk Science Hub

Are you a healthcare professional?

Cardiometabolic Health Congress (CMHC 2026) 15 - 17 October 2026

Time to insulin initiation after escalating to semaglutide 2.0 mg versus switching to tirzepatide among adults with type 2 diabetes receiving semaglutide 1.0 mg

Authors :

Gang Fang¹; Chalak Muhammad¹; Caroline Swift¹; Josh Noone¹; Michael Liang¹; Sherif Mehanna¹; Prachi Priyadashini²; Kathryn Tierney³

Affiliations

View Details Hide Details

Download poster (.pdf)

Keywords

Diabetes

Congress poster

GLP-1 RA

Semaglutide

RWE